Custom cancer vaccine tested in brain tumor patients
NCT ID NCT03223103
Summary
This early-phase study is testing whether a personalized vaccine made from a patient's own tumor, given alongside a device that uses electric fields to fight cancer (Tumor Treating Fields), is safe and well-tolerated. It involves 13 adults with newly diagnosed glioblastoma who have completed initial surgery, radiation, and chemotherapy. The main goal is to check for side effects and see if the body's immune system responds to the vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Conditions
Explore the condition pages connected to this study.